PharmaShots | Incisive News in 3 Shots

Subscribe Now

Transplant Ineligible Patients

Janssen's Darzalex (daratumumab) Combination Regimen Receives EC's Approval for Transplant Ineligible Patients with Newly Diagnosed Multiple Myeloma

Janssen's Darzalex (daratumumab) Combination Regimen Receives EC's Approval for Transplant Ineligible Patients with Newly Diagnose...

November 20, 2019

Janssen's Darzalex (daratumumab) Combination Regimen Receives Health Canada Approval for Transplant Ineligible Patients with Multiple Myeloma

Janssen's Darzalex (daratumumab) Combination Regimen Receives Health Canada Approval for Transplant Ineligible Patients with Multi...

October 31, 2019

Janssen's Darzalex (daratumumab) Receives MHLW's Approval for Transplant Ineligible Patients with Multiple Myeloma in Japan

Janssen's Darzalex (daratumumab) Receives MHLW's Approval for Transplant Ineligible Patients with Multiple Myeloma in Japan

August 22, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us